Cited by

• Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges.

  Kong L, Birkeland AC. Kong L, et al. Cancers (Basel). 2021 Apr 14;13(8):1874. doi: 10.3390/cancers13081874. Cancers (Basel). 2021. PMID: 33919778 Free PMC article. Review.
• ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.

  Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB 3rd, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster H, Hong TS, Innocenti F, Iqbal A, Jacobs SA, Kennecke HF, Lee JJ, Lieu CH, Lenz HJ, Lindwasser OW, Montagut C, Odisio B, Ou FS, Porter L, Raghav K, Schrag D, Scott AJ, Shi Q, Strickler JH, Venook A, Yaeger R, Yothers G, You YN, Zell JA, Kopetz S. Dasari A, et al. Nat Rev Clin Oncol. 2020 Dec;17(12):757-770. doi: 10.1038/s41571-020-0392-0. Epub 2020 Jul 6. Nat Rev Clin Oncol. 2020. PMID: 32632268 Free PMC article. Review.
• Screening for colorectal cancer: established and emerging modalities.

  Pawa N, Arulampalam T, Norton JD. Pawa N, et al. Nat Rev Gastroenterol Hepatol. 2011 Nov 1;8(12):711-22. doi: 10.1038/nrgastro.2011.205. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22045159 Review.
• Implementing prognostic and predictive biomarkers in CRC clinical trials.

  Van Schaeybroeck S, Allen WL, Turkington RC, Johnston PG. Van Schaeybroeck S, et al. Nat Rev Clin Oncol. 2011 Feb 15;8(4):222-32. doi: 10.1038/nrclinonc.2011.15. Nat Rev Clin Oncol. 2011. PMID: 21321566 Review.
• Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.

  Jo P, Azizian A, Salendo J, Kramer F, Bernhardt M, Wolff HA, Gruber J, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J. Jo P, et al. Int J Mol Sci. 2017 May 27;18(6):1140. doi: 10.3390/ijms18061140. Int J Mol Sci. 2017. PMID: 28554991 Free PMC article.